Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
No independent research group has conducted a properly powered, double-blind, placebo-controlled trial of topical GHK-Cu for skin aging
Our most recent Synchrony Symposia conference featured a talk by Charles Niesen MD, President of AMS Therapeutics, who presented the results of an open-label trial of ETS on 25 minimally-verbal, non-epileptic children and young adults with ASD
Injectable is superior for systemic effects, internal tissue repair, and when maximum bioavailability is needed
The rationale for titrating upward over time, rather than starting at the target dose, mirrors the approach taken with other metabolic peptides: the goal is to identify the minimum effective dose for each individual while monitoring for tolerability
US$ 27.96
US$ 24.00
US$ 23.25
